CJC 1295 no DAC / Ipamorelin

Description

CJC-1295 (no DAC) / Ipamorelin Blend pairs a short-acting 29-residue GHRH analog with a highly selective pentapeptide GHS-R1a agonist to amplify physiologic, pulse-like growth-hormone release. This product contains CJC-1295 No DAC (5mg) and Ipamorelin (5mg) blended together in a single vial.

Compound Background
CJC-1295 (no DAC) / Ipamorelin Blend pairs a short-acting 29-residue GHRH analog with a highly selective pentapeptide GHS-R1a agonist to amplify physiologic, pulse-like growth-hormone release. This product contains CJC-1295 No DAC (5mg) and Ipamorelin (5mg) blended together in a single vial.

Quality standards

Greater than 99% pure
LPS/Endotoxins
Heavy metals
Sterility guaranteed
Sourcing standards

Raw ingredients manufactured by an FDA registered & audited supplier following cGMP standards
Finished peptides 0.22 µm sterile-filtered (aseptically processed) and produced in a GMP facility
Tested by a US FDA registered & audited third-party analytical lab accredited by ISO/IEC and U.S. Department of Ecology

Always Quality-Tested, Verified With Third Party COA’s
At every step, we prioritize quality by conducting rigorous third-party testing on all our products. These tests focus on four key characteristics identity, purity, sterility, and endotoxicity ensuring that each batch meets the highest standards for safety and performance, with independent third party Certificates of Analysis (COAs) to verify our commitment to excellence.

Identity Test
Identity testing ensures that the product contains the correct ingredient as labeled, verifying its authenticity and matching it to established reference standards.

Purity Test
Purity and concentration testing verifies that the ingredient is present in the correct amount, with a purity of 98% or higher to meet stringent quality standards.

Sterility Test
Sterility testing ensures that the product is completely free from bacteria, fungi, and other microorganisms.